Newswise — WASHINGTON, D.C. (March 8 2011) -- Viruses can penetrate every part of the body, making them potentially good tools for gene therapy or drug delivery. But with our immune system primed to seek and destroy these foreign invaders, delivering therapies with viruses is currently inefficient and can pose a significant danger to patients.
Now scientists at the University of Pennsylvania have engineered a virus with potential to solve this problem. They describe the new virus today at the 55th Annual Biophysical Society Meeting in Baltimore, MD.
"We would like to find a way to avoid the immune system and maximize the dose delivered to a tumor or diseased tissue," explains professor Dennis Discher of the University of Pennsylvania. He and his colleagues have created a lentiviral vector that expresses CD47, the "marker of self" protein, on its surface. The protein gives cells a free license from macrophages, the immune system's policemen.
"This marker of self protein is found on all of our cells and tames our immune system," says Discher, senior study author. Discher explains that every cell is like a driver. A macrophage ‘policeman’ pulls each cell over at a traffic stop and checks its drivers license -- the marker protein. "The policeman says go on if it's valid. If not, then the macrophage eats you," he says.
By tagging CD47 with green fluorescent protein, the team confirmed that the engineered virus, which is hundreds of times smaller than human cells, was carrying the marker of self. "Assessing the expression of the protein on the surface of an individual virus has been a real biophysical challenge, addressed with a combination of single molecule fluorescence methods and atomic force microscopy," says lead author Nisha Sosale, a graduate student at the University of Pennsylvania.
In cell culture experiments in the laboratory, the engineered virus passed inspection and was eaten less frequently by macrophages. "It looks like, by engineering the viral surface, we have made the viruses look like self," says Discher.
This work was funded by the National Institutes of Health.
The presentation, "Reducing Immune Response Against Lentiviral Vectors: Lentiviral Vector Presentation of CD47, the 'Marker of Self'" by Nisha Sosale, Richard K. Tsai, Irena Ivanovska, and Dennis E. Discher is at 1:45 p.m. on Tuesday, March 8, 2011 in the Baltimore Convention Center, Hall C. ABSTRACT: http://tinyurl.com/4wc4o2q
MORE MEETING INFORMATION
Each year, the Biophysical Society Annual Meeting brings together more than 6,000 scientists and hosts more than 4,000 poster presentations, 200 exhibits, and more than 20 symposia. The largest meeting of its type in the world, the Biophysical Society Annual Meeting retains its small-meeting flavor through its subgroup meetings, platform sessions, social activities, and committee programs.
Meeting Home Page:
General Meeting Information:
The Biophysical Society invites credentialed journalists, freelance reporters working on assignment, and public information officers to attend its Annual Meeting for free. For more information on registering as a member of the press, please contact Ellen Weiss at firstname.lastname@example.org or 240-290-5606. Also see: http://www.biophysics.org/Registration/Press/tabid/2148/Default.aspx
ABOUT THE BIOPHYICAL SOCIETY
The Biophysical Society, founded in 1956, is a professional, scientific society established to encourage development and dissemination of knowledge in biophysics. The society promotes growth in this expanding field through its annual meeting, monthly journal, and committee and outreach activities. Its over 9,000 members are located throughout the U.S. and the world, where they teach and conduct research in colleges, universities, laboratories, government agencies, and industry. For more information on the society or the 2011 Annual Meeting, visit www.biophysics.org